Gail Boudreaux

CIK: 0001287920

Transaction Breakdown

Open Market Buys (P)5 (35.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)3 (21.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ELV

Elevance Health, Inc.

DirectorOfficer

TGT

TARGET CORP

Director

Discretionary Trading P&L

Holdings

Transaction History (14 total)

ELV
Elevance Health, Inc.
Jul 17, 2026
Purchase(P)
Direct
680 shares at avg. $366.41$249K
ELV
Elevance Health, Inc.
Jul 17, 2026
Purchase(P)
Direct
2K shares at avg. $368.25$753K
TGT
TARGET CORP
Mar 11, 2026
Award(A)
Direct
2.7K shares-
ELV
Elevance Health, Inc.
Mar 3, 2026
Tax Payment(F)
Direct
1.7K shares at avg. $284.03$493K
ELV
Elevance Health, Inc.
Mar 2, 2026
Award(A)
Direct
10.5K shares-
ELV
Elevance Health, Inc.
Mar 2, 2026
Tax Payment(F)
Direct
6.7K shares at avg. $294.07$2.0M
ELV
Elevance Health, Inc.
Mar 2, 2026
Award(A)
Direct
16.2K shares-
ELV
Elevance Health, Inc.
Jul 18, 2025
Purchase(P)
Direct
5.1K shares at avg. $287.12$1.5M
ELV
Elevance Health, Inc.
Jul 18, 2025
Purchase(P)
Direct
2.3K shares at avg. $286.07$668K
ELV
Elevance Health, Inc.
Jul 18, 2025
Purchase(P)
Direct
1.1K shares at avg. $287.96$302K
TGT
TARGET CORP
Mar 12, 2025
Award(A)
Direct
2.9K shares-
ELV
Elevance Health, Inc.
Mar 3, 2025
Tax Payment(F)
Direct
10.4K shares at avg. $395.50$4.1M
ELV
Elevance Health, Inc.
Mar 3, 2025
Award(A)
Direct
10.6K shares-
ELV
Elevance Health, Inc.
Mar 3, 2025
Award(A)
Direct
15.6K shares-

		Type	Shares	Price		Ownership
Jul 17, 2026	ELV Elevance Health, Inc.	Purchase(P)	680	$366.41	$249,159	Direct
Jul 17, 2026	ELV Elevance Health, Inc.	Purchase(P)	2,045	$368.25	$753,071	Direct
Mar 11, 2026	TGT TARGET CORP	Award(A)	2,682	-	$0	Direct
Mar 3, 2026	ELV Elevance Health, Inc.	Tax Payment(F)	1,736	$284.03	$493,076	Direct
Mar 2, 2026	ELV Elevance Health, Inc.	Award(A)	10,527	-	$0	Direct
Mar 2, 2026	ELV Elevance Health, Inc.	Tax Payment(F)	6,713	$294.07	$1,974,092	Direct
Mar 2, 2026	ELV Elevance Health, Inc.	Award(A)	16,153	-	$0	Direct
Jul 18, 2025	ELV Elevance Health, Inc.	Purchase(P)	5,116	$287.12	$1,468,906	Direct
Jul 18, 2025	ELV Elevance Health, Inc.	Purchase(P)	2,334	$286.07	$667,687	Direct
Jul 18, 2025	ELV Elevance Health, Inc.	Purchase(P)	1,050	$287.96	$302,358	Direct
Mar 12, 2025	TGT TARGET CORP	Award(A)	2,946	-	-	Direct
Mar 3, 2025	ELV Elevance Health, Inc.	Tax Payment(F)	10,396	$395.50	$4,111,618	Direct
Mar 3, 2025	ELV Elevance Health, Inc.	Award(A)	10,620	-	-	Direct
Mar 3, 2025	ELV Elevance Health, Inc.	Award(A)	15,587	-	-	Direct

1-14 of 14 transactions

About BOUDREAUX GAIL

BOUDREAUX GAIL (SEC CIK 0001287920) files insider reports with the SEC as President and CEO of Elevance Health, Inc. (ELV) and Director of TARGET CORP (TGT).

Signal8 holds 6 ownership filings by BOUDREAUX GAIL, all Form 4s, filed between Mar 5, 2025 and Jul 17, 2026. Those filings report 14 transactions, from Mar 3, 2025 to Jul 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on BOUDREAUX GAIL's filings is in INDIANAPOLIS, IN.

Recent filings by BOUDREAUX GAIL

Jul 17, 2026: Open-market purchases of ELV shares (2 lines, Form 4, code P).
Mar 11, 2026: Grant or award of TGT shares (Form 4, code A).
Mar 3, 2026: Tax withholding of ELV shares (Form 4, code F).
Mar 2, 2026: Grant or award of ELV shares (Form 4, code A).
Mar 2, 2026: Tax withholding of ELV shares (Form 4, code F).

Other insiders filing for Elevance Health, Inc. (ELV)

Kaye Mark, EVP & CFO
Wessling Erin M, EVP & Chief Legal Officer
Craig Ryan R, EVP & Chief HR Officer
PERU RAMIRO G, Director
Penczek Ronald W, CAO & Controller
Dixon Robert L JR, Director

How to read Form 4 transaction codes